Evidence map›Paper›PMID 33022226›Full record

ArticleNeuron2020

Survival and Motor Phenotypes in FVB C9-500 ALS/FTD BAC Transgenic Mice Reproduced by Multiple Labs.

Lien Nguyen, Lauren A Laboissonniere, Shu Guo, Federica Pilotto, Olivier Scheidegger, Angelina Oestmann, Jennetta W Hammond, Herman Li, Anu Hyysalo, Roosa Peltola and 6 more

Abstract read
In one paragraph

Article in Neuron, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. MARK2 regulates C9orf72 repeat-associated non-AUG translation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Cryptic intronic transcriptional initiation generates efficient endogenous mRNA templates for C9orf72-associated RAN translation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microbiome and micronutrient in ALS: From novel mechanisms to new treatments.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lien NguyenCenter for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.
Lauren A LaboissonniereCenter for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.
Shu GuoCenter for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.
Federica PilottoDepartment of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Olivier ScheideggerDepartment of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland.
Angelina OestmannDepartment of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland.
Jennetta W HammondCenter for Neurotherapeutics Discovery, Departments of Neurology, Pediatrics, Neuroscience, and Microbiology and Immunology, University of Rochester, Rochester, NY 14618, USA.
Herman LiCenter for Neurotherapeutics Discovery, Departments of Neurology, Pediatrics, Neuroscience, and Microbiology and Immunology, University of Rochester, Rochester, NY 14618, USA.
Anu HyysaloInstitute of Biotechnology, University of Helsinki, 00790 Helsinki, Finland.
Roosa PeltolaInstitute of Biotechnology, University of Helsinki, 00790 Helsinki, Finland.
Amrutha PattamattaCenter for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.
Tao ZuCenter for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA.
Merja H VoutilainenInstitute of Biotechnology, University of Helsinki, 00790 Helsinki, Finland.
Harris A GelbardCenter for Neurotherapeutics Discovery, Departments of Neurology, Pediatrics, Neuroscience, and Microbiology and Immunology, University of Rochester, Rochester, NY 14618, USA.
Smita SaxenaDepartment of Neurology, Inselspital University Hospital Bern, 3010 Bern, Switzerland.
Laura P W RanumCenter for NeuroGenetics, Department of Molecular Genetics and Microbiology, College of Medicine, Genetics Institute, University of Florida, Gainesville, FL 32610, USA; McKnight Brain Institute, Norman Fixel Institute for Neurological Disease, University of Florida, Gainesville, FL 32610, USA. Electronic address: ranum@ufl.edu.

Funding

Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTDR01NS098819 · NINDS · UNIVERSITY OF FLORIDA · PI Laura P.W Ranum, Tao Zu · 2016 to 2026
$5.2M
Molecular Genetic Characterization of SCA8R37NS040389 · NINDS · UNIVERSITY OF FLORIDA · PI RANUM, LAURA P.W · 2015 to 2021
$4.5M
NINDS NIH HHS R01 NS098819NINDS NIH HHS R37 NS040389
6 · The paper itself

Abstract

Mordes et al. (2020) did not detect the survival or motor phenotypes in C9orf72 BAC transgenic mice originally described by Liu et al. (2016). We discuss methodological differences between the Mordes and Liu studies, several additional studies in which survival and motor phenotypes were found, and possible environmental and genetic effects. First, Nguyen et al. (2020) showed robust ALS/FTD phenotypes in C9-BAC versus non-transgenic (NT) mice and that α-GA

Indexed as

Amyotrophic Lateral SclerosisFrontotemporal DementiaAnimalsC9orf72 ProteinDisease Models, AnimalDNA Repeat ExpansionMiceMice, TransgenicPhenotypeC9orf72 ProteinALS/FTDC9orf72FVB strain backgroundmicrosatellite repeatmotor neuron diseaseRAN proteinsrepeat associated non-AUG (RAN) translationrepeat expansion mutationseizurestransgenic mouse models

Identifiers

PMID33022226
PMCPMC8281452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.